CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Broker Recommendations Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE 00:00:02 03/10/2026 +04			5-day change	1st Jan Change
290.19 ^USD	+1.17%		-0.90%	+45.47%

09-30	UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175	MT
09-29	PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing	MT

Broker Recommendations

09-30	UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175	MT
09-28	Jefferies Adjusts PT on Charles River Laboratories International to $340 From $305, Maintains Buy Rating	MT
09-25	Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says	MT
09-25	Deutsche Bank Raises Price Target on Charles River Laboratories International to $320 From $300, Keeps Buy Rating	MT
09-25	RBC Raises Price Target on Charles River Laboratories International to $322 From $282, Keeps Outperform Rating	MT
09-25	Evercore ISI Adjusts PT on Charles River Laboratories International to $330 From $320, Maintains Outperform Rating	MT
09-25	Mizuho Adjusts PT on Charles River Laboratories International to $295 From $264, Keeps Neutral Rating	MT
09-25	Barclays Adjusts PT on Charles River Laboratories International to $330 From $300, Keeps Overweight Rating	MT
09-25	TD Cowen Adjusts PT on Charles River Laboratories International to $325 From $300, Maintains Buy Rating	MT
09-25	Baird Adjusts PT on Charles River Laboratories International to $334 From $291, Keeps Outperform Rating	MT
09-17	Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating	MT
09-11	Evercore ISI Adjusts PT on Charles River Laboratories International to $320 From $300, Maintains Outperform Rating	MT
08-10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT
08-10	Rothschild & Co Redburn Adjusts PT on Charles River Laboratories International to $318 From $241, Maintains Buy Rating	MT
08-06	Barclays Adjusts Price Target on Charles River Laboratories International to $300 From $220	MT
08-06	RBC Adjusts PT on Charles River Laboratories International to $282 From $215, Keeps Outperform Rating	MT
08-06	Deutsche Bank Adjusts Charles River Laboratories International PT to $300 From $260, Maintains Buy Rating	MT
08-06	JPMorgan Upgrades Charles River Laboratories International to Overweight From Neutral, Adjusts PT to $310 From $180	MT
07-13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT
07-13	Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating	MT
07-13	Mizuho Adjusts Price Target on Charles River Laboratories International to $230 From $192, Maintains Neutral Rating	MT
07-09	Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
07-07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT
06-18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT